SenesTech Inc. (NASDAQ: SNES) Webcast at Lytham Fall

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
218
SenesTech Inc. (NASDAQ: SNES) Webcast at Lytham Fall Investor Conference Highlights Company’s Innovation and Growth with New Solution for Rodent Control

- Rat populations have created concerns for centuries because of their potential to be a vector for diseases, their destruction of infrastructure, and their consumption or spoilage of stored food supplies
- Arizona-based SenesTech Inc. is now introducing its new Evolve(TM) Soft Bait as a companion to its patented ContraPest(R) liquid product as means of shifting rodent control methods from lethal poisons to preventative birth control formulations, with Evolve(TM) Soft Bait representing a big step into a major new market
- The company recently discussed its operation and plans for the near future during a webcast presentation as part of Lytham Partners’ Fall 2023 Investor Conference
- SenesTech has produced successes during testing at West Coast and East Coast poultry farms, and has achieved new client agreements that extend to the countries of Maldives and South Africa

Rodent control innovator SenesTech (NASDAQ: SNES) is delivering a new method of administering its unique, patented contraceptive technology that serves as a form of birth control in both male and female rats, making SenesTech’s solution to the rat population more readily accessible and appealing to pest management companies as well as consumers who prefer non-liquid baits.

The company’s new trademarked Evolve(TM) Soft Bait is an important non-liquid addition to SenesTech’s portfolio, which includes the liquid ContraPest(R) bait brand that has been its flagship product (https://nnw.fm/q7QnB ). Since non-liquid forms of control products are preferred by rodent control professionals, Evolve(TM) Soft Bait is a strong entry for the company into this huge new market.

SenesTech CEO Joel Fruendt and CFO Tom Chesterman discussed the strategy behind Evolve(TM) in a Lytham Partners Fall 2023 Investor Conference webcast presentation earlier this month (https://nnw.fm/v82QT ).

While ContraPest(R) has been “very palatable” to rodents and “keeps the rats coming back for more,” Fruendt said, only about 5 percent of current rodenticide formulations are in liquid form — the vast majority of the market uses solids. Pest management businesses represent a significant market for SenesTech’s new product.

“. . . we are … releasing a soft bait formulation which provides the unique attributes of proven fertility control in an industry-familiar soft bait format demanded by many, including big box retailers, key e-commerce channels and leading pest management professionals,” Fruendt said. “When I took over as CEO at SenesTech, soft bait is one of the key items I quickly identified as a need for us to steepen the curve. I believe its introduction … will be transformative for our business.”

Fruendt labeled rodent control “one of the world’s most challenging problems,” but noted solutions have thus far focused on lethal poisons that “seek to control the death rate” with limited success.

“The challenge, as we see it, is the incredible rate of reproduction of the rats. Given sufficient food, water and harborage, two breeding rats can result in 15,000 offspring after a single year,” he said. “In fact, the largest pest company in the world, Rentokil, commissioned an interactive study, The Rise of Rats, that revealed how a pair of rats could produce nearly half a billion descendants in just three years,” Fruendt added. “Half a billion! You cannot poison them, or trap them or gas them fast enough to overcome their fertility.”

Evolve(TM) will be available for direct sale to pest management professionals, and to the broader consumer market through distributors, on the company’s e-commerce portal and through big box retailers.

The company expects agribusiness and the pest management industry to be crucial to its future success. Currently, about 50 percent of its revenue comes from small e-commerce orders. SenesTech also sees potential in local government partnerships.

“As we are seeing significant increases within the government vertical driven by deployments in California and New England, our experience here is that our customers in the government sector require a longer sales cycle but are very sticky once they get on board. Hopefully, this will provide us a long-term tail wind,” Fruendt said.

Chesterman noted that the company’s most recent financial report for Q2 showed that revenue was up 31 percent sequentially compared to Q1, and Fruendt noted revenue has been consistently growing with an 87 percent CAGR over the past few years.

“We’ve experienced rapid growth over the past few years,” Chesterman said.

“Most recent trends confirm that growth is accelerating as our initiatives put place in the first half of the year take hold,” he added. “Our current goal is to take $1 million out of the annual cash expenses and we’re well on our way to achieving that goal. … (And) we have no long-term debt.”

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://nnw.fm/SNES

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

SenesTech Inc. (SNES) Stock Research Links

SNES Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changshan's Tourism Boom: 22.8% Increase Over Holiday

Updated Category News Views 88

Changshan Grabs Attention This National Day You know, I blinked twice when I saw Changshan's tourist numbers this year. During the 2026 National Day holiday, they managed to snag 503,000 visitors. That's up by a whopping 22.8% from last year. If that doesn't grab your attention, I don't know what will. We're talking record numbers here, folks, and that's the kind of...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 51

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
VeriSilicon's GCNanoOptimaV Transforms Wearable Tech

Updated Category News Views 105

Revving Up Wearables with Next-Gen Graphics Well, folks, VeriSilicon's at it again, rolling out some cutting-edge technology in the form of their spanking new GCNanoOptimaV GPU IP. If you're scratching your head wondering what this means for your wrist-bound gadgets, hang tight—I'm about to spell it out. Architectural Innovations: Striking the Balance Here's the scoop...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 35

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Taiwantrade Introduces AI Sourcing Assistant: ASTRA

Updated Category News Views 121

Revolutionizing AI-Powered Global Sourcing Here's the scoop from Taipei: Taiwantrade's just dropped ASTRA, their brand-spanking-new AI sourcing assistant, and it's got the industry buzzing. When it comes to cutting through the clutter and finding the right supplier, this could change the game for how international buyers scrape deals out of Taiwan. Simplifying Complex...

Continue Reading
APEC CEO Summit Marries Innovation and Global Ties

Updated Category News Views 21

Shenzhen: The Heartbeat of Future Business Shenzhen isn't just a city on the map. It's an exploding innovation powerhouse, a place where global business leaders will rub shoulders this November for the 2026 APEC CEO Summit. This ain't your average conference, my friends. CCPIT (China's national trade pushers) are hosting it from November 17 to 18, promising a powerhouse...

Continue Reading
AAN Seeks Donations to Drive Crucial Brain Research

Updated Category News Views 101

Boosting Brain Horizons: The Need for Donations Urgency clings to the air like smoke around a campfire when it comes to funding brain research. The American Academy of Neurology (AAN) knows this, and they've kicked off their year-end giving campaign, trying to rope in every penny they can muster for the AAN Research Program. With brain diseases lining up like unwanted...

Continue Reading
Seniors and Cybersecurity: Tackling Holiday Threats

Updated Category News Views 90

Battle Against the Holiday Cyber Threats This ain't just about slipping on an ugly sweater this holiday season. The ugly truth is as the colder weather rolls around, so do the cyber vultures—praying on the unsuspecting, especially our seniors. Fraudsters are cranking up the heat, exploiting online shopping sprees, hefty travel plans, and even the warm embrace of a...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
New Player in Options Trading: Mercury Alerts Launches

Updated Category News Views 28

Enter Mercury Alerts in a Changing Trading Landscape Damn, if there ain't some days that throw us a curveball, today's one of them. Since Cboe pulled the plug on the beloved Trade Alert, it's like chopping off a trader's lifeline without a backup. Just when everyone was getting cozy with the way Trade Alert fed the options flow into our screens, here comes Harmeet Goindi...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Upcoming Class Action Against Walgreens for WBA Shareholders

Updated Category News Views 146

Join the Upcoming Class Action Against Walgreens for WBA Shareholders The Gross Law Firm has issued an important notice for shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) regarding a potential class action lawsuit. If you purchased shares of WBA within the specified dates, you may want to consider your options for participation. Class Action Overview This...

Continue Reading
US Employment Surge Sparks Optimism in Asian Markets

Updated Category News Views 187

US Employment Surge Sparks Optimism in Asian Markets By Jamie McGeever As Asian markets prepare to open, the global economic landscape is shifting dramatically, spurred by astonishing U.S. employment figures. This unexpected data has shifted market perceptions and prompted investors to reconsider their strategies. Strong September Non-Farm Payrolls Report The report on...

Continue Reading
Block, Inc. Investors Urged to Connect with Legal Support Now

Updated Category News Views 161

Understanding Your Rights as a Block, Inc. Investor For investors of Block, Inc. looking to recover their losses, it's crucial to understand the legal avenues available to them. The recent issues surrounding Block should encourage affected investors to seek assistance promptly. How to Recover Losses The Portnoy Law Firm is available to help investors navigate the...

Continue Reading
Key Takeaways from Implantica AG's Annual General Meeting

Updated Category News Views 204

Highlights from Implantica AG's Annual General Meeting On a recent date, the annual general meeting (AGM) of Implantica AG (publ) took place in Ruggell. This important gathering allowed shareholders to review key proposals and resolutions put forth by the board of directors, all of which were adopted. Below is a detailed overview of the notable decisions made during this...

Continue Reading
BRIUMVI's 5-Year Trials Show Significant Efficacy and Safety

Updated Category News Views 116

Key Findings from BRIUMVI's 5-Year Trials TG Therapeutics, Inc. (NASDAQ:TGTX) has revealed impressive results from its long-term Phase 3 trials, ULTIMATE I & II, which focus on BRIUMVI (ublituximab-xiiy) for treating relapsing forms of multiple sclerosis (RMS). These findings were presented at the respected European Committee for Treatment and Research in Multiple...

Continue Reading